Femme et Homme
- | Pays :
- South Africa
- | Organes : -
- | Spécialités : -
Extrait
This study will assess the safety and immunogenicity of a GSK Biologicals' candidate TB vaccine administered at 0, 1 months to healthy adults living in a TB-endemic region. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.
Critère d'inclusion
- Tuberculosis (TB)